Mispro offers access to state-of-the-art vivarium facilities for early-stage non-GLP in vivo drug development studies. Our clients span a range of research fields, including:
Mispro offers Biosafety level 1 (BSL-1) and Biosafety level 2 (BSL-2) research environments for early-stage preclinical non-GLP pharmacology, safety tox, and efficacy studies with mice and rat models. Common in vivo study designs we support in our vivarium research facilities include:
Mispro's mission is to enable innovations in science by giving founding scientists control over their studies in a world-class research environment and with best-in-class supporting services for laboratory animal research.
Mispro provides an optimal research environment for companies pursuing novel, innovative, and proprietary therapeutic modalities and drug delivery systems. Whether your lab is on the cutting edge of gene therapies, viral vectors, or focused on innovative small and large molecule delivery systems, our team of specialists can work with you to equip your space and develop study protocols to support your customized approach.
Our clients are pursuing advancements in drug and therapeutic product development across multiple pathways, including: